Exelixis
EXEL
#2109
Rank
C$10.22 B
Marketcap
$35.84
Share price
-1.53%
Change (1 day)
23.67%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Net assets

Net assets on the balance sheet as of June 2024 : C$2.87 B

According to Exelixis's latest financial reports the company has C$2.87 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exelixis - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$3.00 B-11.07%
2022-12-31$C$3.37 B20.69%
2021-12-31$C$2.79 B16.75%
2020-12-31$C$2.39 B9.64%
2019-12-31$C$2.18 B24.45%
2018-12-31$C$1.75 B390.22%
2017-12-31$C$0.35 B198.48%
2016-12-31$C$0.12 B-161.39%
2015-12-31$-C$0.2 B46.82%
2014-12-31$-C$0.14 B-289%
2013-12-31$C$70.46 M-76.15%
2012-12-31$C$0.29 B220.47%
2011-12-31$C$92.19 M-140.34%
2010-12-31$-C$0.23 B32.5%
2009-12-31$-C$0.18 B150.91%
2008-12-31$-C$68.75 M-182%
2007-12-31$C$83.83 M-20.53%
2006-12-31$C$0.10 B58.15%
2005-12-31$C$66.7 M20.65%
2004-12-31$C$55.29 M-73.88%
2003-12-31$C$0.21 B-23.81%
2002-12-31$C$0.27 B-26.48%
2001-12-31$C$0.37 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$23.63 B 721.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$106.13 B 3,591.58%๐Ÿ‡ซ๐Ÿ‡ท France
C$59.20 B 1,959.13%๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.15 B 705.24%๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.03 B 179.52%๐Ÿ‡บ๐Ÿ‡ธ USA
C$97.03 B 3,274.86%๐Ÿ‡บ๐Ÿ‡ธ USA
C$119.32 B 4,050.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.95 M-100.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$39.12 M-98.64%๐Ÿ‡บ๐Ÿ‡ธ USA